She started with an overview about the basic terminology and history of stem cell therapy. She explained about the conventional Embryonic stem cells and followed up with their inherent problems. She mentioned some of the ways to tap stem cells without using Embryonic stem cells. The newer method of reprogramming adult differentiated cells into stem cells (known as "induced pleuripotent stem cells") was also described using the examples of Parkinson's disease. The second part of the talk was on the use in CNS disorders in general. The final part of the talk was focused on use of stem cell therapy in Temporal lobe epilepsy. It is an understudied area, and the findings from the rat studies that she presented showed some of the limitations in our present knowledge of stem cell therapy. Though seizure frequency decreased, the cognitive dysfunctions remained poor or even worsened. She concluded by summarizing the pros and cons, and future prospects of stem cell therapy in CNS disorders.